Our Team

A. Craig Lockhart, M.D., MHS, FASCO, is Chief of the Division of Hematology & Oncology in the MUSC Department of Medicine and Associate Director of Clinical Science at Hollings Cancer Center. With over 20 years of experience conducting clinical trials, a key part of his role as Associate Director is facilitating efforts to bring scientific discoveries from Hollings' laboratories into clinical application through clinical trials.

John Kaczmar, M.D., is the Clinical Trials Office Deputy Medical Director and Director of the Phase 1 Clinical Tials Program at MUSC Hollings Cancer Center. Dr. Kaczmar also serves as Director of the Anderson Advanced Cancer Therapy Clinic which is a specialized unit that provides a team of clinicians who are completely dedicated to the needs of patients participating in Phase 1 clinical trials. Dr. Kaczmar is a medical oncologist who specializes in caring for patients with head and neck cancers.

Medical School: Andhra Medical College, Visakhapatnam, India
Residency: Internal Medicine, Saint Joseph Hospital, Chicago, IL
Fellowship: Hematology and Oncology, Drexel University/Hahnemann University Hospital, Philadelphia PA
Additional degree: Master's in Public Health, East Tennessee State University
Clinical and Research Interests: Treatment of acute leukemia, myelodysplastic disorders, and understanding the novel targetable mechanisms in myelodysplastic syndromes in the clinical setting. He also enjoys teaching and training future generations of medical professionals.

Assistant Professor

John Kaczmar, M.D., is the Clinical Trials Office Deputy Medical Director and Director of the Phase 1 Clinical Tials Program at MUSC Hollings Cancer Center. Dr. Kaczmar also serves as Director of the Anderson Advanced Cancer Therapy Clinic which is a specialized unit that provides a team of clinicians who are completely dedicated to the needs of patients participating in Phase 1 clinical trials. Dr. Kaczmar is a medical oncologist who specializes in caring for patients with head and neck cancers.

A. Craig Lockhart, M.D., MHS, FASCO, is Chief of the Division of Hematology & Oncology in the MUSC Department of Medicine and Associate Director of Clinical Science at Hollings Cancer Center. With over 20 years of experience conducting clinical trials, a key part of his role as Associate Director is facilitating efforts to bring scientific discoveries from Hollings' laboratories into clinical application through clinical trials.

Medical School: Ross University, School of Medicine, Portsmouth, Dominica
Residency: Internal Medicine, Henry Ford Hospital
Fellowship: Hematology-Oncology, Henry Ford Hospital

Dr. Wrangle provides consultation to investigators as they navigate the trial development process. Whether it is connecting to potential funding partners or facilitating collaboration among other researchers at MUSC or other cancer centers, HART supports the efficient activation of new investigator-initiated clinical trials.